Search results
Author(s):
Deepak Natarajan
Added:
3 years ago
Primary percutaneous coronary intervention (PCI) is the treatment of choice in the management of acute ST-segment elevation myocardial infarction (STEMI). It has been constantly observed that, despite restoring good epicardial flow with PCI, myocardial perfusion at the cellular level remains impaired in nearly 50 % of STEMI patients. This led to the development of a new class of antiplatelet…
View more
Author(s):
Michael Tsang
,
Sanjit Jolly
Added:
3 years ago
Many advances have been made in the management of ST elevation myocardial infarction (STEMI) over the past three decades.1 This is owed to insight into role that thrombus has in the obstruction of the infarct-related artery (IRA) and the subsequent cascade of the myocardial ischaemia, cell oedema and myocardial necrosis. The institution of reperfusion therapy has revolutionised the care of…
View more
Author(s):
Fizzah A Choudry
,
Roshan P Weerackody
,
Daniel A Jones
,
et al
Added:
3 years ago
Over the last few decades, primary percutaneous coronary intervention (PCI) has revolutionised the treatment of ST-elevation myocardial infarction (STEMI) with rapid recanalisation of the infarct-related epicardial vessel, resulting in smaller infarct size and a substantial reduction in adverse clinical endpoints.1,2 However, suboptimal myocardial reperfusion is documented to occur in a…
View more
Author(s):
Michael Haude
Added:
3 years ago
Myocardial infarction (MI) is the leading cause of death worldwide in both men and women.1 An impending infarction is recognised by ST elevation, which is predominantly the result of an occlusive thrombosis in a coronary artery. An immediate goal in MI is to restore blood flow through the occluded coronary artery. Reperfusion is carried out using primary percutaneous coronary intervention (PCI)…
View more
Author(s):
Philippe Garot
,
Bertrand Cormier
,
Jérôme Horvilleur
Added:
3 years ago
Left atrial appendage closure (LAAC) has been shown to be non-inferior to warfarin in decreasing the risk of stroke and systemic embolism in patients with AF.1–3 In addition to peri-procedural complications (tamponade, device migration, procedure-related stroke or embolism, and vascular complications), there has been growing concern recently about the occurrence of late complications, especially…
View more
Author(s):
Roberto Diletti
Added:
6 years ago
Interview with Roberto Diletti from Erasmus Medical Centre, Rotterdam, The Netherlands at EuroPCR 2017 on Impact of Thrombus Burden & Removal on Very Long-Term Clinical Outcomes in AMI Patients
Filmed by Radcliffe Cardiology on-site at EuroPCR 2017.
View more
MGuard Embolic Protection Stent
Author(s):
Ricardo Costa
,
Alexandre Abizaid
,
Jean Fajadet
,
et al
Added:
3 years ago
Article
Author(s):
Alexandre Abizaid
Added:
3 years ago
In treating thrombus-loaded lesions through percutaneous coronary intervention (PCI) in the settings of acute myocardial infarction (MI), saphenous vein grafts (SVGs) and acute coronary syndromes (ACS), distal embolisation is a recognised prevalent occurrence, adversely affecting reperfusion and mortality rates. Thus, efficient management of embolisation, in terms of both reduced occurrence and…
View more
Author(s):
Kintis Konstantinos
,
Mantis Christos
,
Papadakis Emmanouel
,
et al
Added:
4 years ago
Author(s):
Krishnaraj S Rathod
,
Stephen M Hamshere
,
Tawfiq R Choudhury
,
et al
Added:
3 years ago
Primary percutaneous coronary intervention (PPCI) is the optimal treatment strategy for restoring coronary blood flow in the infarct related artery (IRA) and salvaging myocardium in patients with ST elevation myocardial infarction (STEMI).1,2 Despite this, PPCI fails to restore optimal myocardial perfusion in up to 40 % of patients despite restoring epicardial artery patency as evidenced by…
View more